Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2012 1
2013 1
2016 2
2017 1
2018 3
2019 2
2020 4
2021 4
2022 2
2023 7
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.
von Dach E, Albrich WC, Brunel AS, Prendki V, Cuvelier C, Flury D, Gayet-Ageron A, Huttner B, Kohler P, Lemmenmeier E, McCallin S, Rossel A, Harbarth S, Kaiser L, Bochud PY, Huttner A. von Dach E, et al. Among authors: mccallin s. JAMA. 2020 Jun 2;323(21):2160-2169. doi: 10.1001/jama.2020.6348. JAMA. 2020. PMID: 32484534 Free PMC article. Clinical Trial.
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study.
Pirnay JP, Djebara S, Steurs G, Griselain J, Cochez C, De Soir S, Glonti T, Spiessens A, Vanden Berghe E, Green S, Wagemans J, Lood C, Schrevens E, Chanishvili N, Kutateladze M, de Jode M, Ceyssens PJ, Draye JP, Verbeken G, De Vos D, Rose T, Onsea J, Van Nieuwenhuyse B; Bacteriophage Therapy Providers; Bacteriophage Donors; Soentjens P, Lavigne R, Merabishvili M. Pirnay JP, et al. Nat Microbiol. 2024 Jun;9(6):1434-1453. doi: 10.1038/s41564-024-01705-x. Epub 2024 Jun 4. Nat Microbiol. 2024. PMID: 38834776 Free PMC article.
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial.
Leitner L, Ujmajuridze A, Chanishvili N, Goderdzishvili M, Chkonia I, Rigvava S, Chkhotua A, Changashvili G, McCallin S, Schneider MP, Liechti MD, Mehnert U, Bachmann LM, Sybesma W, Kessler TM. Leitner L, et al. Among authors: mccallin s. Lancet Infect Dis. 2021 Mar;21(3):427-436. doi: 10.1016/S1473-3099(20)30330-3. Epub 2020 Sep 16. Lancet Infect Dis. 2021. PMID: 32949500 Clinical Trial.
Current State of Compassionate Phage Therapy.
McCallin S, Sacher JC, Zheng J, Chan BK. McCallin S, et al. Viruses. 2019 Apr 12;11(4):343. doi: 10.3390/v11040343. Viruses. 2019. PMID: 31013833 Free PMC article. Review.
Innovations in Phage Therapy for Urinary Tract Infection.
Leitner L, Kessler TM, McCallin SE. Leitner L, et al. Among authors: mccallin se. Eur Urol Focus. 2024 Sep;10(5):722-725. doi: 10.1016/j.euf.2024.07.006. Epub 2024 Jul 23. Eur Urol Focus. 2024. PMID: 39048403 Free article. Review.
Guiding phage therapy with genomic surveillance.
Leitner L, McCallin S. Leitner L, et al. Among authors: mccallin s. Nat Microbiol. 2024 Nov;9(11):2799-2800. doi: 10.1038/s41564-024-01836-1. Nat Microbiol. 2024. PMID: 39468245 No abstract available.
Phages and phage-borne enzymes as new antibacterial agents.
McCallin S, Drulis-Kawa Z, Ferry T, Pirnay JP, Nir-Paz R; ESGNTA – ESCMID study group for non-traditional antibacterials. McCallin S, et al. Clin Microbiol Infect. 2025 Jun;31(6):910-921. doi: 10.1016/j.cmi.2023.10.018. Epub 2023 Oct 20. Clin Microbiol Infect. 2025. PMID: 37866680 Review.
32 results